Kristin McLarty

644 total citations
15 papers, 516 citations indexed

About

Kristin McLarty is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Kristin McLarty has authored 15 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Kristin McLarty's work include HER2/EGFR in Cancer Research (10 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Kristin McLarty is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Kristin McLarty collaborates with scholars based in Canada, United Kingdom and United States. Kristin McLarty's co-authors include Raymond M. Reilly, Bart Cornelissen, Susan J. Done, Deborah A. Scollard, Danny L. Costantini, Katherine A. Vallis, Kathy Chun, Veerle Kersemans, Helen Lee and Conrad Chan and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Journal of Nuclear Medicine and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Kristin McLarty

15 papers receiving 514 citations

Peers

Countries citing papers authored by Kristin McLarty

Since Specialization

Citations

This map shows the geographic impact of Kristin McLarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristin McLarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristin McLarty more than expected).

Fields of papers citing papers by Kristin McLarty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristin McLarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristin McLarty. The network helps show where Kristin McLarty may publish in the future.

Co-authorship network of co-authors of Kristin McLarty

This figure shows the co-authorship network connecting the top 25 collaborators of Kristin McLarty. A scholar is included among the top collaborators of Kristin McLarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristin McLarty. Kristin McLarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Positron-Emission Tomography Imaging of the TSPO with [ ¹⁸ F]FEPPA in a Preclinical Breast Cancer Model 2013 ·Cancer Biotherapy and Radiopharmaceuticals ·Neil Vasdev, David E. Green, Douglass Vines, Kristin McLarty, Patrick N. McCormick, Matthew Moran, Sylvain Houle, Alan A. Wilson, Raymond M. Reilly	18
2	A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT 2011 ·EJNMMI Research ·Conrad Chan, Deborah A. Scollard, Kristin McLarty, (unknown), Raymond M. Reilly	33
3	Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice 2011 ·Nuclear Medicine and Biology ·Kristin McLarty, Matthew Moran, Deborah A. Scollard, Conrad Chan, Nesrin Sabha, (unknown), Abhijit Guha, JoAnne McLaurin, Mark Nitz, Sylvain Houle, Alan A. Wilson, Raymond M. Reilly, Neil Vasdev	15
4	Antitumor Effects and Normal-Tissue Toxicity of ¹¹¹In-Nuclear Localization Sequence-Trastuzumab in Athymic Mice Bearing HER-Positive Human Breast Cancer Xenografts 2010 ·Journal of Nuclear Medicine ·Danny L. Costantini, Kristin McLarty, Helen Lee, Susan J. Done, Katherine A. Vallis, Raymond M. Reilly	61
5	Micro-SPECT/CT with ¹¹¹In-DTPA-Pertuzumab Sensitively Detects Trastuzumab-Mediated HER2 Downregulation and Tumor Response in Athymic Mice Bearing MDA-MB-361 Human Breast Cancer Xenografts 2009 ·Journal of Nuclear Medicine ·Kristin McLarty, Bart Cornelissen, Zhongli Cai, Deborah A. Scollard, Danny L. Costantini, Susan J. Done, Raymond M. Reilly	58
6	¹⁸F-FDG Small-Animal PET/CT Differentiates Trastuzumab-Responsive from Unresponsive Human Breast Cancer Xenografts in Athymic Mice 2009 ·Journal of Nuclear Medicine ·Kristin McLarty, (unknown), Deborah A. Scollard, Susan J. Done, Douglass Vines, David E. Green, Danny L. Costantini, Raymond M. Reilly	33
7	¹¹¹ In-Labeled Immunoconjugates (ICs) Bispecific for the Epidermal Growth Factor Receptor (EGFR) and Cyclin-Dependent Kinase Inhibitor, p27 ^Kip1 2009 ·Cancer Biotherapy and Radiopharmaceuticals ·Bart Cornelissen, Veerle Kersemans, Kristin McLarty, (unknown), Raymond M. Reilly	11
8	In vivo monitoring of intranuclear p27kip1 protein expression in breast cancer cells during trastuzumab (Herceptin) therapy 2009 ·Nuclear Medicine and Biology ·Bart Cornelissen, Veerle Kersemans, Kristin McLarty, (unknown), Katherine A. Vallis, Raymond M. Reilly	8
9	The pharmacokinetics, normal tissue toxicity and anti-tumor effects of [111]In-NLS-trastuzumab in mice bearing HER2-overexpressing breast cancer xenografts 2009 ·Danny L. Costantini, Kristin McLarty, Helen Lee, Susan J. Done, Katherine A. Vallis, Raymond M. Reilly	2
10	Trastuzumab-Resistant Breast Cancer Cells Remain Sensitive to the Auger Electron–Emitting Radiotherapeutic Agent ¹¹¹In-NLS-Trastuzumab and Are Radiosensitized by Methotrexate 2008 ·Journal of Nuclear Medicine ·Danny L. Costantini, (unknown), Kristin McLarty, Katherine A. Vallis, Raymond M. Reilly	66
11	Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts 2008 ·European Journal of Nuclear Medicine and Molecular Imaging ·Kristin McLarty, Bart Cornelissen, Deborah A. Scollard, Susan J. Done, Kathy Chun, Raymond M. Reilly	103
12	The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of 111In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin) 2008 ·Nuclear Medicine and Biology ·Bart Cornelissen, Kristin McLarty, Veerle Kersemans, Raymond M. Reilly	31
13	Molecular Imaging as a Tool for Personalized and Targeted Anticancer Therapy 2007 ·Clinical Pharmacology & Therapeutics ·Kristin McLarty, Raymond M. Reilly	32
14	Properties of [111In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection 2007 ·Nuclear Medicine and Biology ·Bart Cornelissen, Kristin McLarty, Veerle Kersemans, Deborah A. Scollard, Raymond M. Reilly	10
15	Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells 2007 ·Nuclear Medicine and Biology ·Bart Cornelissen, (unknown), Kristin McLarty, (unknown), Raymond M. Reilly	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact